Advertisement

Browse Subject Areas

?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

Combination chemotherapy

Primary ocular-adnexal non-Hodgkin Lymphoma in a Peruvian cohort: An 18-year experience

Renato Luque-Benavides, Gabriel De la Cruz Ku, [ ... ], Daniel Enriquez-Vera

Study protocol: A randomized controlled trial of chemoradiotherapy versus chemotherapy as neoadjuvant therapy for resectable pancreatic cancer (CSGO-HBP-027)

Yoshito Tomimaru, Hirofumi Akita, [ ... ], Hidetoshi Eguchi

Postoperative swallowing recovery in oral and oropharyngeal cancer: A prospective analysis of functional changes and adjuvant therapy effects

Loan Thi Hong Nguyen, Duc Tan Vo, Truc Thanh Thai, Xuan Quang Ly

A cost-effectiveness analysis comparing pembrolizumab combined with chemotherapy versus chemotherapy alone for advanced biliary tract cancer: US and China perspectives

Chunhua Zhang, Hua Liang, [ ... ], Yumei Nong

Safety and efficacy of radiotherapy combined with immunotherapy in limited-stage small cell lung cancer a single-arm meta-analysis and systematic review

Li Yu, Xinlin Yu, [ ... ], Ran Cui

Hepatic arterial infusion is effective in patients with unresectable colorectal liver metastases refractory to standard systemic chemotherapy: A retrospective cohort study

Masatsugu Ishii, Osamu Itano, [ ... ], Satoshi Itano

Cost-effectiveness analysis of benmelstobart and anlotinib plus chemotherapy versus standard chemotherapy in first-line treatment for extensive-stage small cell lung cancer: Perspectives from the United States and China

Wenwang Lang, Jiangbo Wang, [ ... ], Lingyue Huang

Analysis of adverse drug reactions in 507 cases of Tislelizumab: A real-world retrospective study based on data from Guangxi, China

Shaohuan Lu, Dajian Chen, [ ... ], Guangyi Meng

Cost-effectiveness analysis of toripalimab combined with nab-paclitaxel as a first-line treatment for advanced TNBC in the US

Ping Chen, Dan Qiao, [ ... ], Rendi Tian

Tislelizumab plus chemotherapy versus chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A cost-effectiveness analysis

Zhiwei Zheng, Huide Zhu, Ling Fang

A Comparison of neoadjuvant chemotherapy and concurrent chemoradiotherapy for for FIGO 2018 stage IB3/IIA2 Cervical squamous cell carcinoma: Long-term efficacy and safety in a resource-limited setting

Renxian Xie, Keyan Xie, [ ... ], Chuangzhen Chen

Shortcoming of ypStage staging system: Lack of differentiation for preoperative treatment

Peizhun Du, Jinzhe Zhou, [ ... ], Cheng'en Hu

Study of PEG-rhG-CSF for the prevention of neutropenia in concurrent chemoradiotherapy for nasopharyngeal carcinoma

Lu Yang, Lei Yu, [ ... ], Guobo Du

Advertisement

Create a weekly email alert for: Combination chemotherapy

You can change these options by clicking profile then "Alerts and Notifications"